Biomarkers associated with COVID-19 disease progression
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID‐19 Disease
K Keykavousi, F Nourbakhsh… - … journal of analytical …, 2022 - Wiley Online Library
As the COVID‐19 pandemic continues, there is an urgent need to identify clinical and
laboratory predictors of disease severity and prognosis. Once the coronavirus enters the …
laboratory predictors of disease severity and prognosis. Once the coronavirus enters the …
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus
A subgroup of COVID-19 patients develop very severe disease with requirement for ICU
treatment, ventilation, and ECMO therapy. Laboratory tests indicate that the immune and …
treatment, ventilation, and ECMO therapy. Laboratory tests indicate that the immune and …
Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19)
B Christensen, EJ Favaloro, G Lippi… - … in thrombosis and …, 2020 - thieme-connect.com
Over the past few months, Coronavirus Disease 2019 (COVID-19) has spread across much
of the world leading to a pandemic. Many infected individuals do not experience signs or …
of the world leading to a pandemic. Many infected individuals do not experience signs or …
[HTML][HTML] Biomarkers for prognosis and treatment response in COVID-19 patients
During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …
all analytes can change, presenting a correlation with disease severity and survival; …
COVID19 biomarkers: What did we learn from systematic reviews?
S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
[HTML][HTML] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta …
BM Henry, MHS De Oliveira, S Benoit… - Clinical Chemistry and …, 2020 - degruyter.com
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …
need for identification of clinical and laboratory predictors for progression towards severe …
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19
G Xue, X Gan, Z Wu, D Xie, Y Xiong, L Hua… - International …, 2020 - Elsevier
Background Patients with severe coronavirus disease 2019 (COVID-19) develop acute
respiratory distress and multi-system organ failure and are associated with poor prognosis …
respiratory distress and multi-system organ failure and are associated with poor prognosis …
The most important biomarker associated with coagulation and inflammation among COVID-19 patients
LZ Hong, ZX Shou, DM Zheng, X Jin - Molecular and Cellular Biochemistry, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) induced by SARS-Cov-2 can be related to
coagulopathy. Also, the infection-induced inflammatory changes are found in patients with …
coagulopathy. Also, the infection-induced inflammatory changes are found in patients with …
The role of biomarkers in diagnosis of COVID-19–A systematic review
M Kermali, RK Khalsa, K Pillai, Z Ismail, A Harky - Life sciences, 2020 - Elsevier
Aims As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries
and affected over three million confirmed people. We review different biomarkers to evaluate …
and affected over three million confirmed people. We review different biomarkers to evaluate …